| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Keybanc analyst Justin Patterson initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Sector Weight rating.
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...
Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.
Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he ...
Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-lo...
https://www.youtube.com/watch?v=xagrobF4q1k
Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on heal...
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31.
